Compared with normal tissue, COMMD1 mRNA and protein levels are overexpressed in NSCLC patients and COMMD1 functions as a prognostic marker for the ADC subtype of NSCLC. This evidence concerns the gene COMMD1 and non-small cell lung carcinoma.